Vaginal bleeding after menopause: what your body is really telling you

What postmenopausal bleeding really is—and why it is never "harmless"

In my clinical practice, I regularly hear the same phrase: "I didn't want to make a big deal of it." A 51-year-old woman waits six weeks before seeking medical advice because she thinks it might be residual hormonal activity, an insignificant peculiarity. I understand where this reluctance comes from. But this is exactly the kind of bleeding that should never wait.

Menopause is officially diagnosed after 12 consecutive months without menstruation. This simple definition has precise implications: once this milestone has been reached, the endometrium—the tissue lining the inside of the uterus—should no longer behave like a cyclical lining. It should no longer bleed. Ever. So if you bleed after three years without menstruation, it is not your body reviving old hormonal habits. It is a signal that warrants investigation.

These figures are not intended to cause alarm. They are intended to provide context. The good news is that most causes are treatable and often not serious. The bad news is that it is impossible to distinguish harmless endometrial atrophy from early endometrial cancer without a clinical examination and appropriate investigations. No doctor can determine this by sight alone. Neither can you.

All possible causes—from the most common to the most serious

What makes this clinically challenging—and what general practice sometimes handles too quickly—is that benign and serious causes often present in almost identical ways. Light, brown bleeding that occurs only once. It could be vaginal atrophy. It could also be endometrial cancer at a very early stage, with an excellent prognosis if detected at precisely that point.

A clinical paradox that conventional medicine rarely explains: endometrial atrophy—an endometrium that becomes drastically thinner as estrogen levels fall—is the most common benign cause of PMB. Intuition would suggest that thinner tissue bleeds less. The opposite is true. A severely atrophied endometrium has fragile blood vessels that can cause spontaneous, minor contact bleeding, perfectly mimicking an abnormal signal when it is not. But ruling it out without an examination would be a major clinical error.

What the gynecologist will try to rule out—and how

The first consultation for postmenopausal bleeding follows a fairly precise protocol. Knowing this protocol beforehand is not about anticipating the answers—it is about understanding why certain tests are requested and not leaving with unanswered questions that you never voiced.

Transvaginal ultrasound: the starting point

The first-line examination is a transvaginal ultrasound. It measures the thickness of the endometrium: the threshold generally used in a postmenopausal woman is 4 to 5 mm. Below this value, the risk of endometrial cancer is very low. Above it, further investigations are necessary. This is not an absolute rule—I have cared for patients with an endometrial thickness of 3 mm and a polyp that was not visible on standard ultrasound—but it is the first clinical reference point.

Endometrial biopsy and hysteroscopy

When an ultrasound reveals a structural abnormality or when bleeding persists without an identified cause, an endometrial biopsy is performed—a tissue sample taken in a doctor’s office or as a day-hospital procedure. Hysteroscopy—visual examination of the uterine cavity through the natural passage—allows the cavity to be visualized and biopsied at the same time. It sounds intimidating on paper, but it is very well tolerated in the vast majority of cases, often without general anesthesia.

What about the Pap smear?

If your last Pap smear was more than three years ago, your gynecologist will probably perform one during the same appointment. Cervical cancer remains rare in women whose previous Pap smears were normal—but menopause does not eliminate the need for screening.

When hormonal treatment or medication may be involved

If you are taking hormone replacement therapy (HRT), the situation is different — but no less closely monitored. Unexpected bleeding while on HRT may simply indicate a formulation imbalance, irregular absorption, or a need for dose adjustment. It may also indicate something else. The rule remains the same: it must be evaluated.

One point I systematically address in consultations, but few doctors mention spontaneously: anticoagulants — including preventive-dose aspirin and direct oral anticoagulants (DOACs) — can cause or worsen genital bleeding in postmenopausal women, particularly when associated with vaginal atrophy. This is not a contraindication to these treatments — they are often life-saving — but it is information that should be included in the overall assessment.

What conventional medicine still takes too little into account in this context: non-gynecological causes of bleeding. Terminal hematuria during urination, or bleeding of hemorrhoidal or rectal origin—these situations are underestimated during consultations because they require the patient to carefully observe the precise context in which the bleeding occurs. A 48-hour clinical journal can save significant diagnostic time.

What you can do before your gynecological appointment

The absolute priority is to seek medical advice. Not in three weeks. This week. If your primary care physician cannot see you promptly, go to the gynecological emergency department of a maternity hospital or medical center. Postmenopausal bleeding is a legitimate reason for urgent consultation—do not let politeness or fear of “bothering” anyone delay an assessment that could change your prognosis.

This is what I often tell my patients: your body speaks to you in the only language it knows. Bleeding has no ill intent—but it deserves a medical response. The functional and integrative medicine I practice is not an alternative to a gynecological assessment. It comes afterward, as a complement. But it never replaces it.

Once serious causes have been ruled out—and statistically, this is the most likely scenario—it is time to consider overall hormonal balance. The drop in estrogen that accompanies menopause is not an insignificant detail: it affects the endometrium, the vaginal lining, the skin, the bones, sleep, mood, and cognition. This is where targeted micronutrition and phytoestrogens can play a real role—not to treat bleeding, but to support the hormonal transition in all its duration and complexity.